![]() Avid Bioservices Avid Bioservices, formerly Peregrine Pharmaceuticals, is a biopharmaceutical company. | ![]() Zogenix Specialty pharmaceutical developing CNS and pain therapies and featuring DosePro needle free delivery technology. | ![]() Amicus Therapeutics Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases. | |
Founding Date | Founding Date 1981 | Founding Date 2006 | Founding Date 2002 |
Type | Type Public | Type Subsidiary | Type Public |
Tags | |||
Locations | Locations Tustin, US HQ | Locations Emeryville, US HQ Maidenhead, GB | Locations Philadelphia, US HQ Northbridge, AU Pointe Claire, CA Paris, FR München, DE Dublin, IE Milano, IT see more |
Employees | Employees 21114% increase | Employees 743% increase | Employees 58415% increase |
Valuation ($) | Valuation ($) 649.4 m | Valuation ($) N/A | Valuation ($) 3.4 b |
Financial | |||
Revenue (est.) | Revenue (est.) $139.9m (FY, 2024) | Revenue (est.) $81.7m (FY, 2021) | Revenue (est.) $634.2m (FY, 2025) |
Cost of goods | Cost of goods $132.6m (FY, 2024) | Cost of goods $4.8m (FY, 2021) | Cost of goods $72.9m (FY, 2025) |
Gross profit | Gross profit $7.3m (FY, 2024) | Gross profit N/A | Gross profit $561.3m (FY, 2025) |
Net income | Net income ($140.8m) (FY, 2024) | Net income ($227.4m) (FY, 2021) | Net income ($27.1m) (FY, 2025) |

Specialty pharmaceutical developing CNS and pain therapies and featuring DosePro needle free delivery technology.
View company
Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.
View company